Search

everythinglearnresearchcommunity

for

Search:↓

Ovarian tumors should be considered when postmenopausal women show signs of virilization.

Using anabolic-androgenic steroids can cause skin problems like acne and hair loss in athletes.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Unmarried women with PCOS in Pakistan face stigma and use various strategies to cope, needing better support and accurate information.

A position effect on the TRPS1 gene causes excessive hair growth in humans and mice.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Two specific SNPs in the TRPS1 gene cause excessive hair growth by altering the protein's structure.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

PCOS affects nearly 25% of female medical and dental students, impacting their academic and social lives.

People distressed by minor skin changes should consult dermatologists with cosmetic expertise, and a public Cosmetic Dermatology Service with mental health support is recommended.

Topical eflornithine effectively reduces facial hair in women and improves quality of life.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Ayurvedic treatment improved PCOS symptoms in a 40-year-old woman.

Ayurvedic treatment, exercise, and a healthy diet can effectively manage PCOD symptoms.

Follicular targeting could improve hirsutism treatment by focusing directly on hair follicles.

A woman had unusual hair growth on one side of her chin without a known cause.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.